Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathological Myeloid Activation After Sepsis and Trauma Subtitle: Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology

NCT05616130 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05616130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05616130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathological Myeloid Activation After Sepsis and Trauma Subtitle: Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology
Lead sponsor
University of Florida
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2022
Completion date
September 30, 2028
Enrollment
255 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic critical illness, immunosuppression, sepsis, trauma injury